Alzheimer's disease (AD) is a severe neurodegenerative disorder characterized by cognitive decline. Prodromal stage of AD, also called mild cognitive impairment (MCI), especially its amnestic type (aMCI), precedes dementia stage of AD. There are currently no reliable diagnostic biomarkers of AD in the blood. Alzheimer's disease is accompanied by increased oxidative stress in brain, which leads to oxidative damage and accumulation of free radical reaction end-products. In our study, specific products of lipid peroxidation in the blood of AD patients were studied. Lipophilic extracts of erythrocytes (AD dementia = 19, aMCI = 27, controls = 16) and plasma (AD dementia = 11, aMCI = 17, controls = 16) were analysed by fluorescence spectroscopy. The level of these products is significantly increased in erythrocytes and plasma of AD dementia and aMCI patients versus controls. We concluded that oxidative stress end-products are promising new biomarkers of AD, but further detailed characterisation of these products is needed.

Department of Medical Chemistry and Clinical Biochemistry 2nd Faculty of Medicine Charles University Prague Czech Republic

International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic

Memory Disorders Clinic Department of Neurology 2nd Faculty of Medicine Charles University Prague and Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256: 183–94. Doi:10.1111/j.1365‐2796.2004.01388.x. PubMed DOI

Sperling RA, Aisen PS, Beckett LA, et al Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7: 280–92. Doi:10.1016/j.jalz.2011.03.003. PubMed DOI PMC

Skoumalová A, Hort J. Blood markers of oxidative stress in Alzheimer's disease. J Cell Mol Med. 2012; 16: 2291–300. PubMed PMC

Dalle‐Donne I, Rossi R, Colombo R, et al Biomarkers of oxidative damage in human disease. Clin Chem. 2006; 52: 601–23. PubMed

Skoumalova A, Rofina J, Schwippelova Z, et al The role of free radical in canine counterpart of senile dementia of the Alzheimer type. Exp Gerontol. 2003; 38: 711–9. PubMed

Hort J, Glosova L, Vyhnalek M, et al The liquor tau protein and beta amyloid in Alzheimer's disease. Cesk Slov Neurol N. 2007; 70: 30–6.

Hort J, Bartos A, Pirttila T, et al Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe. Eur J Neurol. 2010; 17: 90–6. PubMed

Farrall AJ, Wardlaw JM. Blood‐brain barrier: ageing and microvaskular disease – systematic review and metaanalysis. Neurobiol Aging. 2009; 30: 337–52. PubMed

Skoumalova A, Ivica J, Santorova P, et al The lipid peroxidation products as possible markers of Alzheimer's disease in blood. Exp Gerontol. 2011; 46: 38–42. PubMed

Yesavage JA. Geriatric depression Scale. Psychopharmacol Bull. 1988; 24: 709–11. PubMed

Fazekas F, Chawluk JB, Alavi A, et al MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol. 1987; 149: 351–6. PubMed

McKhann G, Drachman D, Folstein M, et al Clinical diagnosis of Alzheimer's disease: report of the NINCDS‐ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34: 939–44. PubMed

Laczo J, Andel R, Vlcek K, et al Spatial navigation and APOE in amnestic mild cognitive impairment. Neurodegener Dis. 2011; 8: 169–77. Doi:10.1159/000321581. PubMed DOI

Goldstein BD, McDonagh EM. Spectrofluorescent detection of in vivo red cell lipid peroxidation in patients treated with diaminodiphenylsulphone. J Clin. Invest. 1976; 57: 1302–7. PubMed PMC

Pratico D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy. Ann NY Acad. Sci. 2008; 1147: 70–8. Doi:10.1196/annals.1427.010. PubMed DOI

Montine TJ, Neely MD, Quinn JF, et al Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med. 2002; 33: 620–6. PubMed

Chio KS, Tappel AL. Synthesis and characterisation of the fluorescent products derived from malondialdehyde and amino acids. Biochemistry. 1969; 8: 155–67. PubMed

Baldeiras I, Santana I, Proenca ET, et al Peripheral oxidative damage in mild cognitive impairment and mild Alzeimer's disease. J Alzheimers Dis. 2008; 15: 117–28. PubMed

Wilhelm J, Herget J. Hypoxia induces free radical damage to rat erythrocytes and spleen: analysis of the fluorescent end‐products of lipid peroxidation. Int J Biochem Cell Biol. 1999; 31: 671–81. PubMed